• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经导管主动脉瓣植入复杂性评分

Transcatheter aortic valve implantation complexity score.

作者信息

Abdelrahman Amr, Bamford Paul, Aktaa Suleman, Hall Rowan, Arockiam Sacchin, Blackman Daniel J, Malkin Christopher, Cunnington Michael, Ali Noman

机构信息

Department of Cardiology, Leeds General Infirmary, Leeds, UK.

The University of Newcastle, Callaghan, New South Wales, Australia.

出版信息

Open Heart. 2025 Jan 4;12(1):e002804. doi: 10.1136/openhrt-2024-002804.

DOI:10.1136/openhrt-2024-002804
PMID:39756818
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11751777/
Abstract

BACKGROUND

Increasing demand for transcatheter aortic valve implantation (TAVI) places greater emphasis on the efficiency of pathways and services. A significant limitation to increasing TAVI capacity is the availability of cardiac catheterisation laboratory time. We have developed a novel complexity scoring system (TAVI ComplEXity; TEX score) which can aid in planning lists with appropriate case selection. To validate the TEX score, we have undertaken a retrospective analysis of TAVI cases. The hypothesis is that increasing TEX score correlates with increased procedural duration and reduced valve academic research consortium (VARC) 3 technical and device success.

METHODS

The TEX score assigns patients to a complexity level of 1 (low), 2 (intermediate) or 3 (high) based on the presence of specific clinical and anatomical variables. For validation purposes, comparisons were made between patients in the three complexity levels with respect to procedural duration as well as VARC-3 technical success, device success and early safety.

RESULTS

The validation study included 1034 consecutive patients who underwent TAVI between June 2021 and October 2023. Of these, 582 (56.3%) were classified as level 1 complexity, 377 (36.5%) level 2 and 75 (7.3%) level 3. Significant differences were observed between the three groups with respect to procedural duration (73.7 min vs 85.6 min vs 136 min; p<0.001), VARC-3 technical success (97.9% vs 96.6% vs 92%; p<0.05) and VARC-3 device success (96.2% vs 92.3% vs 86.6%; p<0.001).

CONCLUSION

The TEX score is a simple tool which allows stratification of patients into three levels of complexity. Increasing complexity levels correlate with increasing procedural duration and reduced VARC-3 technical and device success. This is potentially useful for scheduling patients onto appropriate lists.

摘要

背景

经导管主动脉瓣植入术(TAVI)需求的不断增加,使得对手术流程和服务效率的重视程度更高。增加TAVI手术量的一个重大限制是心导管实验室时间的可用性。我们开发了一种新型的复杂性评分系统(TAVI复杂性;TEX评分),它有助于通过适当的病例选择来安排手术名单。为了验证TEX评分,我们对TAVI病例进行了回顾性分析。假设是TEX评分的增加与手术时间的延长以及瓣膜学术研究联盟(VARC)3技术成功率和器械成功率的降低相关。

方法

TEX评分根据特定临床和解剖学变量的存在情况将患者分为1级(低)、2级(中)或3级(高)复杂性水平。为了验证,对三个复杂性水平的患者在手术时间以及VARC - 3技术成功率、器械成功率和早期安全性方面进行了比较。

结果

验证研究包括2021年6月至2023年10月期间连续接受TAVI手术的1034例患者。其中,582例(56.3%)被归类为1级复杂性,377例(36.5%)为2级,75例(7.3%)为3级。三组在手术时间(73.7分钟对85.6分钟对136分钟;p<0.001)、VARC - 3技术成功率(97.9%对96.6%对92%;p<0.05)和VARC - 3器械成功率(96.2%对92.3%对86.6%;p<0.001)方面存在显著差异。

结论

TEX评分是一种简单的工具,可将患者分为三个复杂性水平。复杂性水平的增加与手术时间的延长以及VARC - 3技术成功率和器械成功率的降低相关。这对于将患者安排到合适的手术名单上可能是有用的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e0d/11751777/26b7ebe43dbf/openhrt-12-1-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e0d/11751777/a0f7f14488c1/openhrt-12-1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e0d/11751777/66f152c9772a/openhrt-12-1-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e0d/11751777/26b7ebe43dbf/openhrt-12-1-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e0d/11751777/a0f7f14488c1/openhrt-12-1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e0d/11751777/66f152c9772a/openhrt-12-1-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e0d/11751777/26b7ebe43dbf/openhrt-12-1-g003.jpg

相似文献

1
Transcatheter aortic valve implantation complexity score.经导管主动脉瓣植入复杂性评分
Open Heart. 2025 Jan 4;12(1):e002804. doi: 10.1136/openhrt-2024-002804.
2
VARC-3 defined outcome of valve-in-valve transcatheter aortic valve implantation in stentless compared with stented aortic bioprostheses.VARC-3定义了无支架与有支架主动脉生物假体相比,经导管主动脉瓣置换术的瓣中瓣植入结局。
Clin Res Cardiol. 2025 Mar;114(3):291-301. doi: 10.1007/s00392-023-02347-5. Epub 2023 Dec 11.
3
Transcatheter Aortic Valve Replacement With Next-Generation Self-Expanding Devices: A Multicenter, Retrospective, Propensity-Matched Comparison of Evolut PRO Versus Acurate neo Transcatheter Heart Valves.经导管主动脉瓣置换术联合新一代自膨式瓣膜:Evolut PRO 与 Acurate neo 经导管心脏瓣膜多中心、回顾性、倾向性匹配比较研究。
JACC Cardiovasc Interv. 2019 Mar 11;12(5):433-443. doi: 10.1016/j.jcin.2018.11.036.
4
First experience with transfemoral transcatheter aortic valve implantation without prior balloon pre-dilatation using a latest generation repositionable and retrievable transcatheter heart valve†.首次使用新一代可重新定位和可回收经导管心脏瓣膜,在未进行球囊预扩张的情况下经股动脉进行经导管主动脉瓣植入术† 。
Interact Cardiovasc Thorac Surg. 2017 May 1;24(5):659-662. doi: 10.1093/icvts/ivw446.
5
Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.经股主动脉瓣置换术治疗症状性重度主动脉瓣狭窄时,爱德华兹·萨皮恩 3 号瓣比爱德华兹 XT 瓣更成功。
Arch Cardiovasc Dis. 2018 Aug-Sep;111(8-9):470-479. doi: 10.1016/j.acvd.2017.05.012. Epub 2017 Nov 8.
6
Sapien 3 Transcatheter Aortic Valve Implantation With Moderate or Without Predilation.使用Sapien 3经导管主动脉瓣植入术,采用中度预扩张或不采用预扩张。
J Invasive Cardiol. 2016 Oct;28(10):421-426.
7
A Direct Comparison of Self-Expandable Portico Versus Balloon-Expandable Sapien 3 Devices for Transcatheter Aortic Valve Replacement: A Case-Matched Cohort Study.经导管主动脉瓣置换术中自膨胀式Portico与球囊扩张式Sapien 3装置的直接比较:一项病例匹配队列研究。
J Invasive Cardiol. 2019 Jul;31(7):E199-E204.
8
A proctoring system to manage the learning curve associated with the introduction of transcatheter aortic valve implantation in Japan.一种用于管理在日本引入经导管主动脉瓣植入术相关学习曲线的监考系统。
Heart Vessels. 2018 Jun;33(6):630-639. doi: 10.1007/s00380-017-1098-9. Epub 2017 Dec 11.
9
Concomitant percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation.经导管主动脉瓣植入术患者同期行经皮冠状动脉介入治疗。
Catheter Cardiovasc Interv. 2024 Jan;103(1):186-193. doi: 10.1002/ccd.30927. Epub 2023 Dec 22.
10
TAVI with the ACURATE neo2 in severe bicuspid aortic valve stenosis: the Neo2 BAV Registry.使用ACURATE neo2经导管主动脉瓣植入术治疗重度二叶式主动脉瓣狭窄:Neo2二叶式主动脉瓣注册研究
EuroIntervention. 2025 Jan 20;21(2):e130-e139. doi: 10.4244/EIJ-D-24-00869.

本文引用的文献

1
Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years.经导管主动脉瓣置换术在五年内的低危患者中的应用。
N Engl J Med. 2023 Nov 23;389(21):1949-1960. doi: 10.1056/NEJMoa2307447. Epub 2023 Oct 24.
2
Coronary Obstruction After Transcatheter Aortic Valve Replacement: Insights From the Spanish TAVI Registry.经导管主动脉瓣置换术后的冠状动脉阻塞:来自西班牙 TAVI 注册研究的见解。
JACC Cardiovasc Interv. 2023 May 22;16(10):1208-1217. doi: 10.1016/j.jcin.2023.03.024.
3
Left ventricular dysfunction before transcatheter aortic valve implantation.
经导管主动脉瓣植入术前的左心室功能障碍
AsiaIntervention. 2019 Jul 20;5(2):110-111. doi: 10.4244/AIJV5I2A18. eCollection 2019 Jul.
4
Transcatheter Aortic Valve Implantation for Severe Pure Aortic Regurgitation With Dedicated Devices.使用专用器械经导管主动脉瓣植入治疗重度单纯主动脉瓣反流
Interv Cardiol. 2022 Jul 21;17:e11. doi: 10.15420/icr.2021.19. eCollection 2022 Jan.
5
TAVI-CT score to evaluate the anatomic risk in patients undergoing transcatheter aortic valve implantation.TAVI-CT 评分评估行经导管主动脉瓣植入术患者的解剖风险。
Sci Rep. 2022 May 9;12(1):7612. doi: 10.1038/s41598-022-11788-3.
6
Uncovering the treatable burden of severe aortic stenosis in the UK.揭示英国严重主动脉瓣狭窄可治疗负担。
Open Heart. 2022 Jan;9(1). doi: 10.1136/openhrt-2021-001783.
7
Urgent transcatheter aortic valve implantation in an all-comer population: a single-centre experience.紧急经导管主动脉瓣植入术在所有患者人群中的应用:单中心经验。
BMC Cardiovasc Disord. 2021 Nov 19;21(1):550. doi: 10.1186/s12872-021-02347-1.
8
Impact of High Body Mass Index on Vascular and Bleeding Complications After Transcatheter Aortic Valve Implantation.高身体质量指数对经导管主动脉瓣植入术后血管和出血并发症的影响。
Am J Cardiol. 2021 Sep 15;155:86-95. doi: 10.1016/j.amjcard.2021.06.015. Epub 2021 Jul 17.
9
Risk scores for prediction of 30-day mortality after transcatheter aortic valve implantation: Results from a two-center study in Norway.经导管主动脉瓣植入术后30天死亡率预测的风险评分:挪威一项两中心研究的结果
Health Sci Rep. 2021 May 6;4(2):e283. doi: 10.1002/hsr2.283. eCollection 2021 Jun.
10
Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research.瓣膜学术研究联合会 3:主动脉瓣临床研究更新终点定义。
J Am Coll Cardiol. 2021 Jun 1;77(21):2717-2746. doi: 10.1016/j.jacc.2021.02.038. Epub 2021 Apr 19.